{"id":"https://genegraph.clinicalgenome.org/r/4c00f38b-1b96-4990-9098-e2df99a34975v1.0","type":"EvidenceStrengthAssertion","dc:description":"The *KCNK4* gene is located on chromosome 11 at 11q13.1 and encodes the potassium channel subfamily K, member 4, a 2-pore domain potassium ion channel that is expressed almost exclusively in the nervous system, and controls the resting membrane potential. *KCNK4* was first reported in relation to autosomal dominant facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth (FHEIG) syndrome in 2018 (Bauer et al., PMID: 30290154). FHEIG syndrome is a rare, multiple congenital anomalies syndrome characterized by variable intellectual disability and/or developmental delay, epilepsy, generalized hypertrichosis, and severe gingival overgrowth. Seven unique missense variants have been reported in 12 probands in 6 publications and in ClinVar (PMIDs: 30290154, 32981868, 37931962, 36683851, 37750049, 39146707. ClinVar: SCV002157627.3, SCV002761982.1) and are included in this curation. The mechanism of pathogenicity at this time is unknown. This gene-disease relationship is also supported by expression in relevant tissues and by biochemical function studies (PMIDs: 32913098, 36225112). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date September 4th, 2024 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4c00f38b-1b96-4990-9098-e2df99a34975","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c65a8f69-11ae-4a17-8e66-b4461a8c877b","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c65a8f69-11ae-4a17-8e66-b4461a8c877b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2025-04-08T15:15:45.580Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/c65a8f69-11ae-4a17-8e66-b4461a8c877b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2024-09-04T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c65a8f69-11ae-4a17-8e66-b4461a8c877b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a31a01bc-d4c1-4a16-9db2-a5dc345d1cdd","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a31a01bc-d4c1-4a16-9db2-a5dc345d1cdd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37750049","allele":{"id":"https://genegraph.clinicalgenome.org/r/166aa07c-7546-45ad-a79a-45b35287487a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.730G>C (p.Ala244Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381066207"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ae567ad7-8a48-434d-bf9e-68f7180b8a27","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae567ad7-8a48-434d-bf9e-68f7180b8a27_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"They investigated the predicted activating effect of the two identified KCNK4 mutations, p.Ala172Glu and p.Ala244Pro. Membrane currents recorded from Chinese hamster ovary (CHO) cells transfected with the mutant channels were much larger and already prominent in the negative potential range. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ae567ad7-8a48-434d-bf9e-68f7180b8a27_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30290154","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2f4f222-c09c-4443-8221-9577b892a662","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.515C>A (p.Ala172Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381165679"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/0b2babbb-101a-41f8-b968-7ee9d25ac98a","type":"EvidenceLine","dc:description":"Score downgraded due to lack of phenotype","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b2babbb-101a-41f8-b968-7ee9d25ac98a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36683851","allele":{"id":"https://genegraph.clinicalgenome.org/r/5435e8d7-620d-49d9-a6f5-06ad46279852","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.698C>T (p.Pro233Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381066120"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b4fc5fb0-6b3a-4d1e-a08f-1fb4ff7ebd6a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4fc5fb0-6b3a-4d1e-a08f-1fb4ff7ebd6a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39146707","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c8ba236-5e8c-432f-a603-a1a909cfb0a6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.415G>A (p.Gly139Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381164596"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/53ebfd0a-1b04-4555-a687-b591823e2395","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53ebfd0a-1b04-4555-a687-b591823e2395_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30290154","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2f4f222-c09c-4443-8221-9577b892a662"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/45f2d76b-6852-45c3-a632-54fcea9de3d8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45f2d76b-6852-45c3-a632-54fcea9de3d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37931962","allele":{"id":"https://genegraph.clinicalgenome.org/r/a2f4f222-c09c-4443-8221-9577b892a662"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9da21c5a-8971-43b2-93f1-1f8a0f156af1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9da21c5a-8971-43b2-93f1-1f8a0f156af1_variant_evidence_item","type":"VariantObservation","dc:source":{"id":"https://identifiers.org/clinvar.submission:SCV002761982.1","type":"dc:BibliographicResource","dc:abstract":"Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge","dc:creator":"GeneDx","dc:date":"2022-12-17","dc:title":"NM_033310.3(KCNK4):c.428G>A (p.Gly143Asp)","about":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1803302"}},"allele":{"id":"https://genegraph.clinicalgenome.org/r/3d422287-64b1-4734-b5d5-bfd7206830da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.428G>A (p.Gly143Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381164715"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2be763d7-4977-4aa1-bccf-515c24dc0828","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2be763d7-4977-4aa1-bccf-515c24dc0828_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36683851","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4083d78-bf6b-4470-b43b-0e88ae7f7af5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.416G>A (p.Gly139Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/3391487"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a330a300-cb3d-40b3-947e-75d9199a2d99","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a330a300-cb3d-40b3-947e-75d9199a2d99_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"They investigated the predicted activating effect of the two identified KCNK4 mutations, p.Ala172Glu and p.Ala244Pro. Membrane currents recorded from Chinese hamster ovary (CHO) cells transfected with the mutant channels were much larger and already prominent in the negative potential range. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a330a300-cb3d-40b3-947e-75d9199a2d99_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30290154","allele":{"id":"https://genegraph.clinicalgenome.org/r/166aa07c-7546-45ad-a79a-45b35287487a"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/6dbcbfff-122c-45f5-9278-5c7e33dc8a2d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6dbcbfff-122c-45f5-9278-5c7e33dc8a2d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32981868","allele":{"id":"https://genegraph.clinicalgenome.org/r/166aa07c-7546-45ad-a79a-45b35287487a"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3783ac79-58d7-498f-8266-731f8f44bb71","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3783ac79-58d7-498f-8266-731f8f44bb71_variant_evidence_item","type":"VariantObservation","dc:source":"https://identifiers.org/clinvar.submission:SCV002761982.1","allele":{"id":"https://genegraph.clinicalgenome.org/r/3d422287-64b1-4734-b5d5-bfd7206830da"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/75546d01-09a1-481b-902c-39610953903c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75546d01-09a1-481b-902c-39610953903c_variant_evidence_item","type":"VariantObservation","dc:source":{"id":"https://identifiers.org/clinvar.submission:SCV002157627.3","type":"dc:BibliographicResource","dc:abstract":"This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 162 of the KCNK4 protein (p.Val162Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of KCNK4-related neurodevelopmental syndrome (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 1393449). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.","dc:creator":"Labcorp Genetics (formerly Invitae), Labcorp","dc:date":"2024-02-28","dc:title":"NM_033310.3(KCNK4):c.484G>A (p.Val162Met)","about":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1393449"}},"allele":{"id":"https://genegraph.clinicalgenome.org/r/2201d59a-d01c-43ce-a91a-b853e336ece2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_033310.3(KCNK4):c.484G>A (p.Val162Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA381165406"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.8},{"id":"https://genegraph.clinicalgenome.org/r/c65a8f69-11ae-4a17-8e66-b4461a8c877b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c65a8f69-11ae-4a17-8e66-b4461a8c877b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a1d6e54-e9ea-4564-b40d-cf13fcaf9dfe","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4785a88-7b42-423c-8f1c-f5c7c5cd2fff","type":"Finding","dc:description":"Epilepsy is a consistent feature of FHEIG syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36225112","rdfs:label":"Gao_Biochemical","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6f63f15b-0a02-4933-b5a8-c02703457b5b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6316353c-5235-4c7a-a251-231bb361b56b","type":"Finding","dc:description":"KCNK4 is expressed only in brain tissues according to GTEx.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32913098","rdfs:label":"GTEx Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Moderate","sequence":10191,"specifiedBy":"GeneValidityCriteria11","strengthScore":6.8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Cy7jbtizs1M","type":"GeneValidityProposition","disease":"obo:MONDO_0032714","gene":"hgnc:6279","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c65a8f69-11ae-4a17-8e66-b4461a8c877b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}